位置:首页 > 蛋白库 > ELN_MOUSE
ELN_MOUSE
ID   ELN_MOUSE               Reviewed;         860 AA.
AC   P54320; Q8C9L8;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   27-JUL-2011, sequence version 2.
DT   03-AUG-2022, entry version 143.
DE   RecName: Full=Elastin;
DE   AltName: Full=Tropoelastin;
DE   Flags: Precursor;
GN   Name=Eln;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=BALB/cJ; TISSUE=Lung;
RX   PubMed=7829060; DOI=10.1006/geno.1994.1467;
RA   Wydner K.S., Sechler J.L., Boyd C.D., Passmore H.C.;
RT   "Use of an intron polymorphism to localize the tropoelastin gene to mouse
RT   chromosome 5 in a region of linkage conservation with human chromosome 7.";
RL   Genomics 23:125-131(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J; TISSUE=Thymus;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION.
RX   PubMed=9607766; DOI=10.1038/30522;
RA   Li D.Y., Brooke B., Davis E.C., Mecham R.P., Sorensen L.K., Boak B.B.,
RA   Eichwald E., Keating M.T.;
RT   "Elastin is an essential determinant of arterial morphogenesis.";
RL   Nature 393:276-280(1998).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Lung, Spleen, and Testis;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
CC   -!- FUNCTION: Major structural protein of tissues such as aorta and nuchal
CC       ligament, which must expand rapidly and recover completely. Molecular
CC       determinant of the late arterial morphogenesis, stabilizing arterial
CC       structure by regulating proliferation and organization of vascular
CC       smooth muscle. {ECO:0000269|PubMed:9607766}.
CC   -!- SUBUNIT: The polymeric elastin chains are cross-linked together into an
CC       extensible 3D network. Forms a ternary complex with BGN and MFAP2.
CC       Interacts with MFAP2 via divalent cations (calcium > magnesium >
CC       manganese) in a dose-dependent and saturating manner. Interacts with
CC       FBLN5 and FBN1. Forms a ternary complex with FBN1 and FBLN2 or FBLN5.
CC       Interacts with MFAP4 in a Ca (2+)-dependent manner; this interaction
CC       promotes ELN self-assembly (By similarity). Interacts with EFEMP2 with
CC       moderate affinity (By similarity). {ECO:0000250|UniProtKB:P04985,
CC       ECO:0000250|UniProtKB:P15502}.
CC   -!- SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular
CC       matrix {ECO:0000250|UniProtKB:P15502}. Note=Extracellular matrix of
CC       elastic fibers. {ECO:0000250|UniProtKB:P15502}.
CC   -!- PTM: Elastin is formed through the cross-linking of its soluble
CC       precursor tropoelastin. Cross-linking is initiated through the action
CC       of lysyl oxidase on exposed lysines to form allysine. Subsequent
CC       spontaneous condensation reactions with other allysine or unmodified
CC       lysine residues result in various bi-, tri-, and tetrafunctional cross-
CC       links. The most abundant cross-links in mature elastin fibers are
CC       lysinonorleucine, allysine aldol, desmosine, and isodesmosine.
CC   -!- PTM: Hydroxylation on proline residues within the sequence motif, GXPG,
CC       is most likely to be 4-hydroxy as this fits the requirement for 4-
CC       hydroxylation in vertebrates. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the elastin family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U08210; AAA80155.1; -; mRNA.
DR   EMBL; AK041860; BAC31084.1; -; mRNA.
DR   EMBL; CH466529; EDL19414.1; -; Genomic_DNA.
DR   EMBL; BC051649; AAH51649.1; -; mRNA.
DR   CCDS; CCDS19725.1; -.
DR   PIR; A55721; EAMS.
DR   RefSeq; NP_031951.2; NM_007925.4.
DR   AlphaFoldDB; P54320; -.
DR   BioGRID; 199433; 3.
DR   IntAct; P54320; 1.
DR   STRING; 10090.ENSMUSP00000015138; -.
DR   PhosphoSitePlus; P54320; -.
DR   MaxQB; P54320; -.
DR   PaxDb; P54320; -.
DR   PRIDE; P54320; -.
DR   ProteomicsDB; 277820; -.
DR   Antibodypedia; 4380; 434 antibodies from 35 providers.
DR   DNASU; 13717; -.
DR   Ensembl; ENSMUST00000015138; ENSMUSP00000015138; ENSMUSG00000029675.
DR   GeneID; 13717; -.
DR   KEGG; mmu:13717; -.
DR   UCSC; uc008zwv.1; mouse.
DR   CTD; 2006; -.
DR   MGI; MGI:95317; Eln.
DR   VEuPathDB; HostDB:ENSMUSG00000029675; -.
DR   eggNOG; ENOG502RYNR; Eukaryota.
DR   GeneTree; ENSGT00730000111510; -.
DR   HOGENOM; CLU_021236_0_0_1; -.
DR   InParanoid; P54320; -.
DR   OMA; KTKTHHR; -.
DR   Reactome; R-MMU-1474228; Degradation of the extracellular matrix.
DR   Reactome; R-MMU-1566948; Elastic fibre formation.
DR   Reactome; R-MMU-2129379; Molecules associated with elastic fibres.
DR   BioGRID-ORCS; 13717; 5 hits in 75 CRISPR screens.
DR   ChiTaRS; Eln; mouse.
DR   PRO; PR:P54320; -.
DR   Proteomes; UP000000589; Chromosome 5.
DR   RNAct; P54320; protein.
DR   Bgee; ENSMUSG00000029675; Expressed in ascending aorta and 269 other tissues.
DR   ExpressionAtlas; P54320; baseline and differential.
DR   Genevisible; P54320; MM.
DR   GO; GO:0062023; C:collagen-containing extracellular matrix; HDA:BHF-UCL.
DR   GO; GO:0071953; C:elastic fiber; IDA:MGI.
DR   GO; GO:0031012; C:extracellular matrix; ISO:MGI.
DR   GO; GO:0005576; C:extracellular region; ISO:MGI.
DR   GO; GO:0005615; C:extracellular space; ISO:MGI.
DR   GO; GO:0005739; C:mitochondrion; HDA:MGI.
DR   GO; GO:0050840; F:extracellular matrix binding; IDA:MGI.
DR   GO; GO:0030023; F:extracellular matrix constituent conferring elasticity; ISO:MGI.
DR   GO; GO:0001974; P:blood vessel remodeling; ISO:MGI.
DR   GO; GO:0030198; P:extracellular matrix organization; IDA:MGI.
DR   GO; GO:0003151; P:outflow tract morphogenesis; ISO:MGI.
DR   GO; GO:0030833; P:regulation of actin filament polymerization; IMP:MGI.
DR   GO; GO:0007519; P:skeletal muscle tissue development; IMP:MGI.
DR   GO; GO:0043149; P:stress fiber assembly; IMP:MGI.
DR   InterPro; IPR003979; Tropoelastin.
DR   PANTHER; PTHR24018; PTHR24018; 1.
PE   1: Evidence at protein level;
KW   Disulfide bond; Extracellular matrix; Hydroxylation; Reference proteome;
KW   Repeat; Secreted; Signal.
FT   SIGNAL          1..27
FT                   /evidence="ECO:0000250|UniProtKB:Q99372"
FT   CHAIN           28..860
FT                   /note="Elastin"
FT                   /id="PRO_0000021164"
FT   MOD_RES         35
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         72
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         84
FT                   /note="Hydroxyproline"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         105
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         123
FT                   /note="Allysine"
FT                   /evidence="ECO:0000250|UniProtKB:P04985"
FT   MOD_RES         127
FT                   /note="Allysine"
FT                   /evidence="ECO:0000250|UniProtKB:P04985"
FT   MOD_RES         217
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         230
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         233
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         253
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         299
FT                   /note="Allysine"
FT                   /evidence="ECO:0000250|UniProtKB:P04985"
FT   MOD_RES         318
FT                   /note="Allysine"
FT                   /evidence="ECO:0000250|UniProtKB:P04985"
FT   MOD_RES         321
FT                   /note="Allysine"
FT                   /evidence="ECO:0000250|UniProtKB:P04985"
FT   MOD_RES         346
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         368
FT                   /note="Allysine"
FT                   /evidence="ECO:0000250|UniProtKB:P04985"
FT   MOD_RES         371
FT                   /note="Allysine"
FT                   /evidence="ECO:0000250|UniProtKB:P04985"
FT   MOD_RES         383
FT                   /note="Hydroxyproline"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         399
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         405
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         410
FT                   /note="Hydroxyproline"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         415
FT                   /note="Hydroxyproline"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         431
FT                   /note="Allysine"
FT                   /evidence="ECO:0000250|UniProtKB:P04985"
FT   MOD_RES         435
FT                   /note="Allysine"
FT                   /evidence="ECO:0000250|UniProtKB:P04985"
FT   MOD_RES         438
FT                   /note="Allysine"
FT                   /evidence="ECO:0000250|UniProtKB:P04985"
FT   MOD_RES         481
FT                   /note="Allysine"
FT                   /evidence="ECO:0000250|UniProtKB:P04985"
FT   MOD_RES         484
FT                   /note="Allysine"
FT                   /evidence="ECO:0000250|UniProtKB:P04985"
FT   MOD_RES         498
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         519
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         534
FT                   /note="Allysine"
FT                   /evidence="ECO:0000250|UniProtKB:P04985"
FT   MOD_RES         595
FT                   /note="Allysine"
FT                   /evidence="ECO:0000250|UniProtKB:P04985"
FT   MOD_RES         599
FT                   /note="Allysine"
FT                   /evidence="ECO:0000250|UniProtKB:P04985"
FT   MOD_RES         603
FT                   /note="Allysine"
FT                   /evidence="ECO:0000250|UniProtKB:P04985"
FT   MOD_RES         617
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         626
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         644
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         653
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         661
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         668
FT                   /note="Allysine"
FT                   /evidence="ECO:0000250|UniProtKB:P04985"
FT   MOD_RES         671
FT                   /note="Allysine"
FT                   /evidence="ECO:0000250|UniProtKB:P04985"
FT   MOD_RES         702
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         719
FT                   /note="Allysine"
FT                   /evidence="ECO:0000250|UniProtKB:P04985"
FT   MOD_RES         723
FT                   /note="Allysine"
FT                   /evidence="ECO:0000250|UniProtKB:P04985"
FT   MOD_RES         783
FT                   /note="Allysine"
FT                   /evidence="ECO:0000250|UniProtKB:P04985"
FT   MOD_RES         786
FT                   /note="Allysine"
FT                   /evidence="ECO:0000250|UniProtKB:P04985"
FT   MOD_RES         832
FT                   /note="4-hydroxyproline"
FT                   /evidence="ECO:0000250"
FT   DISULFID        850..855
FT                   /evidence="ECO:0000250"
FT   CONFLICT        250
FT                   /note="A -> S (in Ref. 1; AAA80155)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   860 AA;  71938 MW;  7C340F2FFFDC92E5 CRC64;
     MAGLTAVVPQ PGVLLILLLN LLHPAQPGGV PGAVPGGLPG GVPGGVYYPG AGIGGLGGGG
     GALGPGGKPP KPGAGLLGTF GAGPGGLGGA GPGAGLGAFP AGTFPGAGAL VPGGAAGAAA
     AYKAAAKAGA GLGGVGGVPG GVGVGGVPGG VGVGGVPGGV GVGGVPGGVG GIGGIGGLGV
     STGAVVPQVG AGIGAGGKPG KVPGVGLPGV YPGGVLPGTG ARFPGVGVLP GVPTGTGVKA
     KAPGGGGAFA GIPGVGPFGG QQPGVPLGYP IKAPKLPGGY GLPYTNGKLP YGVAGAGGKA
     GYPTGTGVGS QAAAAAAKAA KYGAGGAGVL PGVGGGGIPG GAGAIPGIGG IAGAGTPAAA
     AAAKAAAKAA KYGAAGGLVP GGPGVRLPGA GIPGVGGIPG VGGIPGVGGP GIGGPGIVGG
     PGAVSPAAAA KAAAKAAKYG ARGGVGIPTY GVGAGGFPGY GVGAGAGLGG ASPAAAAAAA
     KAAKYGAGGA GALGGLVPGA VPGALPGAVP AVPGAGGVPG AGTPAAAAAA AAAKAAAKAG
     LGPGVGGVPG GVGVGGIPGG VGVGGVPGGV GPGGVTGIGA GPGGLGGAGS PAAAKSAAKA
     AAKAQYRAAA GLGAGVPGFG AGAGVPGFGA GAGVPGFGAG AGVPGFGAGA GVPGFGAGAV
     PGSLAASKAA KYGAAGGLGG PGGLGGPGGL GGPGGLGGAG VPGRVAGAAP PAAAAAAAKA
     AAKAAQYGLG GAGGLGAGGL GAGGLGAGGL GAGGLGAGGL GAGGLGAGGL GAGGGVSPAA
     AAKAAKYGAA GLGGVLGARP FPGGGVAARP GFGLSPIYPG GGAGGLGVGG KPPKPYGGAL
     GALGYQGGGC FGKSCGRKRK
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024